Halozyme Therapeutics
HALO
#2172
Rank
NZ$14.89 B
Marketcap
NZ$126.67
Share price
2.73%
Change (1 day)
25.36%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2025 (TTM): NZ$1.28 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are NZ$1.24 Billion. In 2024 the company made an earning of NZ$0.92 Billion, an increase over its 2023 earnings that were of NZ$0.57 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$1.28 B39.12%
2024 NZ$0.92 B59.94%
2023 NZ$0.57 B39.94%
2022 NZ$0.41 B0.16%
2021 NZ$0.41 B92.2%
2020 NZ$0.21 B-278.96%
2019 -NZ$0.12 Billion-9.45%
2018 -NZ$0.14 Billion-229.51%
2017 NZ$0.10 B-160.48%
2016 -NZ$0.17 Billion216.03%
2015 -NZ$53.39 Million-52.86%
2014 -NZ$0.12 Billion-18.09%
2013 -NZ$0.14 Billion55.88%
2012 -NZ$88.71 Million169.94%
2011 -NZ$32.86 Million-63.44%
2010 -NZ$89.87 Million-7.19%
2009 -NZ$96.83 Million15.91%
2008 -NZ$83.54 Million83.89%
2007 -NZ$45.43 Million78.1%
2006 -NZ$25.51 Million16%
2005 -NZ$21.99 Million45.24%
2004 -NZ$15.14 Million682.42%
2003 -NZ$1.94 Million1659.12%
2002 -NZ$0.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$53.65 B 4,242.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$19.63 B 1,488.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$37.27 B 2,916.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$15.07 B 1,119.98%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-NZ$0.45 Billion-136.20%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
NZ$50.98 M-95.87%๐Ÿ‡บ๐Ÿ‡ธ USA